It is important to develop a new Pharmaceutical Strategy.

COVID has shown us our strengths and weaknesses.

Ultimately it will be crucial to improve the resilience of health care in Europe while ensuring that we continue to be a global leader of pharmaceutical innovation.
RT @EU_Commission: We want medicine to be more accessible, available, and affordable.

Our #EUPharmaStrategy legislative reform proposes a single market of medicines that:

🔸 is patient-centri…

🐦🔗: https://n.respublicae.eu/k_edtstadler/status/1651542632076541953